Keeping Up With Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis

To participate in this activity, please:

Multiple sclerosis (MS) is a chronic, progressive, and disabling inflammatory neurologic condition that causes more disability than any other nontraumatic neurologic condition. Early diagnosis, treatment, and monitoring of disease progression is fundamental to optimizing management of patients with MS. Join Edward Fox, MD, PhD, and Matthew Schindler, MD, PhD, in an interactive case-based roadmap for improved outcomes in patients with MS. In addition to addressing diagnostic challenges, Drs. Fox and Schindler share their insights into integrating advances in the pharmacologic treatment of patients with MS, focusing on the safety and efficacy of targeted therapies.

Course Credit:

1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
0.25 Pharmacology Hours


Opens: 2022-06-22
Closes: 2023-06-22

Target Audience:

This activity was developed for neurologists, physician assistants, nurse practitioners, and allied healthcare professionals who diagnose and manage patients with multiple sclerosis (MS).

This activity is supported by educational grants from Genentech, a member of the Roche Group, and Novartis.

    Presenting Faculty

  • Edward J. Fox, MD, PhD

    Director, MS Clinic of Central Texas
    Central Texas Neurology Consultants, PA
    Clinical Associate Professor, University of Texas Dell Medical School
    Round Rock, Texas

  • Matthew K. Schindler, MD, PhD

    Assistant Professor of Neurology, MS Division
    Perelman School of Medicine
    University of Pennsylvania
    Philadelphia, Pennsylvania